177 related articles for article (PubMed ID: 38394627)
21. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
[TBL] [Abstract][Full Text] [Related]
22. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
[TBL] [Abstract][Full Text] [Related]
23. ART2Dose: A comprehensive dose verification platform for online adaptive radiotherapy.
Lin J; Chen M; Lai Y; Trivedi Z; Wu J; Foo T; Gonzalez Y; Reynolds R; Park C; Yan Y; Godley A; Jiang S; Jia X; Lin MH; Pompos A; Lu W
Med Phys; 2024 Jan; 51(1):18-30. PubMed ID: 37856190
[TBL] [Abstract][Full Text] [Related]
24. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Radiographers at the Helm: Moving Towards Radiographer-Led MR-Guided Radiotherapy.
Hales RB; Rodgers J; Whiteside L; McDaid L; Berresford J; Budgell G; Choudhury A; Eccles CL
J Med Imaging Radiat Sci; 2020 Sep; 51(3):364-372. PubMed ID: 32600981
[TBL] [Abstract][Full Text] [Related]
26. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
Liu F; Ahunbay E; Lawton C; Li XA
Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
[TBL] [Abstract][Full Text] [Related]
27. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
[TBL] [Abstract][Full Text] [Related]
28. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
McDonald BA; Vedam S; Yang J; Wang J; Castillo P; Lee B; Sobremonte A; Ahmed S; Ding Y; Mohamed ASR; Balter P; Hughes N; Thorwarth D; Nachbar M; Philippens MEP; Terhaard CHJ; Zips D; Böke S; Awan MJ; Christodouleas J; Fuller CD;
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1606-1618. PubMed ID: 33340604
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
[TBL] [Abstract][Full Text] [Related]
30. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
[TBL] [Abstract][Full Text] [Related]
31. Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy.
Rabe M; Palacios MA; van Sörnsen de Koste JR; Eze C; Hillbrand M; Belka C; Landry G; Senan S; Kurz C
Med Phys; 2023 May; 50(5):2625-2636. PubMed ID: 36810708
[TBL] [Abstract][Full Text] [Related]
32. Early experience with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac: First 6 months of operation using adapt to shape workflow.
de Leon J; Crawford D; Moutrie Z; Alvares S; Hogan L; Pagulayan C; Jelen U; Loo C; Aylward JD; Condon K; Dunkerley N; Heinke MY; Sampaio S; Simon K; Twentyman T; Jameson MG
J Med Imaging Radiat Oncol; 2022 Feb; 66(1):138-145. PubMed ID: 34643065
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Unity 1.5 T MR-linac plan quality in patients with prostate cancer.
Tanaka S; Kadoya N; Ishizawa M; Katsuta Y; Arai K; Takahashi H; Xiao Y; Takahashi N; Sato K; Takeda K; Jingu K
J Appl Clin Med Phys; 2023 Dec; 24(12):e14122. PubMed ID: 37559561
[TBL] [Abstract][Full Text] [Related]
34. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
Intven MPW; de Mol van Otterloo SR; Mook S; Doornaert PAH; de Groot-van Breugel EN; Sikkes GG; Willemsen-Bosman ME; van Zijp HM; Tijssen RHN
Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
[TBL] [Abstract][Full Text] [Related]
35. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
36. A feasibility study of adaptive radiation therapy for postprostatectomy prostate cancer.
Meyers SM; Winter JD; Obeidi Y; Chung P; Menard C; Warde P; Fong H; McPartlin A; Parameswaran S; Berlin A; Bayley A; Catton C; Craig T
Med Dosim; 2024 Summer; 49(2):150-158. PubMed ID: 37985297
[TBL] [Abstract][Full Text] [Related]
37. Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac.
Dunlop A; Mitchell A; Tree A; Barnes H; Bower L; Chick J; Goodwin E; Herbert T; Lawes R; McNair H; McQuaid D; Mohajer J; Nilawar R; Pathmanathan A; Smith G; Hanson I; Nill S; Oelfke U
Clin Transl Radiat Oncol; 2020 Jul; 23():35-42. PubMed ID: 32395640
[TBL] [Abstract][Full Text] [Related]
38. SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes.
Brennan VS; Burleson S; Kostrzewa C; Godoy Scripes P; Subashi E; Zhang Z; Tyagi N; Zelefsky MJ
Radiother Oncol; 2023 Feb; 179():109441. PubMed ID: 36549340
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Intensity Modulated Radiotherapy Treatment Plans Between 1.5T MR-Linac and Conventional Linac.
Ding S; Li Y; Liu H; Li R; Wang B; Zhang J; Chen Y; Huang X
Technol Cancer Res Treat; 2021; 20():1533033820985871. PubMed ID: 33472549
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy.
Adair Smith G; Dunlop A; Alexander SE; Barnes H; Casey F; Chick J; Gunapala R; Herbert T; Lawes R; Mason SA; Mitchell A; Mohajer J; Murray J; Nill S; Patel P; Pathmanathan A; Sritharan K; Sundahl N; Tree AC; Westley R; Williams B; McNair HA
Radiother Oncol; 2023 Mar; 180():109457. PubMed ID: 36608770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
